Disease / condition

Systemic Lupus Erythematosus clinical trials

Free access to 443 studies·10+ countries·Updated daily79 recruiting
443
Total trials
10+
Countries
10+
Sponsors
79
Recruiting
By phase
N/A180
Phase 291
Phase 162
Phase 351
Phase 426
By status
Completed195
Recruiting79
Not yet recruit...74
Unknown37
Terminated26
Top countries
United States of America106
China44
Egypt14
France13
Japan10
Top sponsors
GlaxoSmithKline27
Assiut University13
UCB Pharma11
AstraZeneca11
Sohag University8
Recent trials
Latest clinical trials for Systemic Lupus Erythematosus
SLCTR_2008_006·Not ApplicableTerminated
Study of Abetimus Sodium in Lupus Patients With History of Renal Disease
La Jolla Pharmaceutical Compan...Argentina, Belarus, Brazil, Czech Republic, Georgia, Germany, HongKong, Hungary, India, Indonesia, N
SLCTR_2015_002·Phase 3Suspended
A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus
Anthera Pharmaceuticals, IncBelarus, Brazil, Colombia, Georgia, Guatemala, HongKong, North Korea, Malaysia, Mexico, Philippines,
NCT06421701·Phase 1Not yet recr...
Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosus
Second Affiliated Hospital, Sc...China
NCT06413511·Phase 1Not yet recr...
A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Moderate to Severe Systemic Lupus Erythematosus
GlaxoSmithKlineUnited States of America
NCT06411249·Phase 4Not yet recr...
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
GlaxoSmithKline
NCT06404723Not yet recr...
The Predictive and Prognostic Values of the Fibrinogen to Albumin Ratio and C-reactive Protien to Albumin Ratio in Systemic Lupus Erythematosus Patients
Sohag University
NCT06400537·Phase 1Not yet recr...
Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus
Wuhan Union Hospital, China
NCT06394063Not yet recr...
Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients
RenJi Hospital
NCT06378736Recruiting
Electroencephalogram Recording in Patients With Systemic Lupus Erythematosus
Northwell HealthUnited States of America
NCT06356740·Phase 2Not yet recr...
Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus
Hospices Civils de LyonFrance
NCT06360068·Phase 2Not yet recr...
A Prospective, Single Arm, Open Label, Proof of Concept Clinical Study of Sulfasalazine in the Treatment of Active Systemic Lupus Erythematosus
Qiong Fu
NCT06340490·Phase 1Not yet recr...
A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)
Guangdong Ruishun Biotech Co.,...China
NCT06349343·Phase 1Not yet recr...
CD19/BCMA HLA-independent TCR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus
Wuhan Union Hospital, China
NCT06327724Recruiting
Belimumab in SLE Synovial Inflammation and Lymph Nodes
Academisch Medisch Centrum - U...Netherlands
NCT06340750·Phase 1Not yet recr...
BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus
Luminary Therapeutics
NCT06333483·Phase 1Recruiting
A Study of CD19 Targeted CAR T Cell Therapy in Patients With Severe, Refractory Systemic Lupus Erythematosus (SLE)
Autolus LimitedUnited Kingdom
NCT06308978·Phase 1Recruiting
FT819 in Moderate to Severe Active Systemic Lupus Erythematosus
Fate TherapeuticsUnited States of America
NCT06297408·Phase 1Not yet recr...
Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus
Shanghai Ming Ju Biotechnology...
NCT06308770Recruiting
Fatigue in Lupus Intervention Programmes (FLIP)
University of EdinburghUnited Kingdom
NCT06255028·Phase 1Not yet recr...
A Study of CNTY-101 in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)
Century Therapeutics, Inc.
About this record

Access comprehensive clinical trial information for Systemic Lupus Erythematosus through Pure Global AI's free database. This collection includes 443 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 79 trials are actively recruiting participants.

Research for Systemic Lupus Erythematosus is being conducted in United States of America, China, Egypt and 7+ other countries. Leading sponsors include GlaxoSmithKline and Assiut University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 443 clinical trials studying Systemic Lupus Erythematosus, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include GlaxoSmithKline, Assiut University, UCB Pharma, among others.